18.07.2022 - Reference is made to the stock exchange notice from Hofseth BioCare ASA ( HBC or the Company ) published on 3 July 2022 regarding the completion of a private placement raising gross proceeds of approximately NOK 141 million through issuance of new .
Reference is made to the stock exchange announcement by Hofseth BioCare ASA (the "Company") on 3 July 2022 regarding completion of a private placement of.
The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Kipervikgata 13, 6003 Ålesund, on 29 April 2022 at 13:00 CET. .
11.03.2022 - Hofseth BioCare (HBC) has been named Best Sustainable Biotech Company 2022 in the Global Health & Pharma Biotechnology Awards. The award is in recognition of HBC’s 15 years of pioneering research and product development, ground-breaking healthcare .